Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Alfredo Franco-Obregon

Tracked across 1 events · 8 articles · First seen Sep 13, 2026 · Last active Sep 15, 2026

Sentiment
15
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 15
Tech
Researchers at the National University of Singapore (NUS) have demonstrated a non-invasive approach for targeted breast cancer therapy using pulsed electromagnetic fields (PEMFs). The study, led by Associate Professor Alfredo Franco-Obregon from the NUS Yong…
Impact: Associate Professor Alfredo Franco-Obregon led the research team and is the key spokesperson for the study. His leadership and expertise are central to the development of the PEMF therapy.
Sep 13, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Alfredo Franco-Obregon live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.